trial
as of 2026-07-01Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis
NCTId NCT06542640
at a glance
— · Recruiting
Enrollment 300 (estimated)
Sponsored by Beth Israel Deaconess Medical Center
Primary completion 2027-06-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
300 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2024-01-01
Primary completion
2027-06-30
Eligibility
ALL · 15 Years · 35 Years
Interventions & indications
Sponsors
Beth Israel Deaconess Medical CenterLead Sponsor
Shanghai Jiao Tong University School of MedicineCollaborator
Florida A&M UniversityCollaborator
Brigham and Women's HospitalCollaborator
Massachusetts General HospitalCollaborator
VA Boston Healthcare SystemCollaborator
National Institute of Mental Health (NIMH)Collaborator
Investigators
1
William R. McFarlane, M.D.Principal Investigator
Sites
1 total
Shanghai, China
Facts & assertions
4 sourced
Enrollment
300
Phase
NA
Primary Completion Date
2027-06-30
Status
RECRUITING
relationships
The graph out of here
drug
drug
drug
lead_sponsor
collaborator
indication
investigator